LB2302 - Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE)

Saturday, October 22, 2022

1:45 PM – 1:57 PM US ET

Location: 206

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Presenting Author(s)

Thomas L. Holland, MD

Associate Professor, Department of Medicine, Division of Infectious Diseases
Duke University Medical Center
Durham, North Carolina, United States

Disclosure: Disclosure(s): Aridis: Advisor/Consultant (); Basilea Pharmaceutica: Advisor/Consultant (); Karius: Advisor/Consultant (); Lysovant: Advisor/Consultant ()

Slides

Co-Author(s)

SC

Sara E. Cosgrove, MD

Professor
Johns Hopkins University Department of Medicine
Baltimore, Maryland, United States

Disclosure: Disclosure(s): Basilea: Advisor/Consultant (); Debiopharma: Advisor/Consultant ()
Sarah B. Doernberg, MD, MAS

Associate Professor
University of California, San Francisco
San Francisco, California, United States

Disclosure: Disclosure(s): Basilea: Advisor/Consultant (); Genentech: Advisor/Consultant (); Gilead: Grant/Research Support (); Johnson and Johnson: Advisor/Consultant (); NIH: Grant/Research Support (); Regeneron: Grant/Research Support ()
OP

Oleksander Pavlov, MD

Professor
Zaycev V.T. Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine, Kharkiv
Kharkiv, Kharkivs'ka Oblast', Ukraine

Disclosure: Disclosure(s): No financial relationships to disclose
IT

Ivan Titov, MD

Regional Clinical Hospital, Regional Clinical Hospital, Ivano-Frankivsk Regional Council
Ivano-Frankivsk, Ivano-Frankivs'ka Oblast', Ukraine

Disclosure: Disclosure(s): No financial relationships to disclose
BA

Boyko Atanasov, MD

Eurohospital Plovdiv
Plovdiv, Plovdiv, Bulgaria

Disclosure: Disclosure(s): No financial relationships to disclose
MA

Maziar Assadi Gehr, MD

Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland

Disclosure: Disclosure(s): Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()
ME

Marc Engelhardt, MD

Dr.
Basilea Pharmaceutica International Ltd
Basel, Basel-Stadt, Switzerland

Disclosure: Disclosure(s): Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()
KH

Kamal Hamed, MD

Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland

Disclosure: Disclosure(s): Basilea Pharmaceutica: previous full time employee of Basilea Pharmaceutica International Ltd (); Lysovant: full time employee of Lysovant ()
DI

Daniel Ionescu, MD

Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland

Disclosure: Disclosure(s): Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()
MJ

Mark Jones, PhD

Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland

Disclosure: Disclosure(s): Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()
MS

Mikael Sauley, MSc

Mr.
Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland

Disclosure: Disclosure(s): Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()
JS

Jennifer Smart, PhD

Sr. Microbiologist, Development
Basilea Pharmaceutica International Ltd
Allschwil, Basel-Landschaft, Switzerland

Disclosure: Disclosure(s): Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()
HS

Harald Seifert, MD

Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne
Cologne, Nordrhein-Westfalen, Germany

Disclosure: Disclosure(s): Basilea Pharmaceutica: Advisor/Consultant (); Debiopharm: Advisor/Consultant (); Eumedica: Advisor/Consultant (); Gilead: Advisor/Consultant (); MSD: Advisor/Consultant (); Shionogi: Advisor/Consultant ()
Timothy C. Jenkins, MD

Associate Professor
Denver Health and Hospital Authority
Denver, Colorado, United States

Disclosure: Disclosure(s): Basilea: Clinical outcomes adjudication committee ()
Nicholas A. Turner, MD, MHSc

Assistant Professor
Duke University Medical Center
Durham, North Carolina, United States

Disclosure: Disclosure(s): No financial relationships to disclose
Vance G. Fowler, Jr, MD, MHS

Professor of Medicine
Duke University Medical Center
Durham, North Carolina, United States

Disclosure: Disclosure(s): Armata Valanbio Akagera Aridis Roche: Advisor/Consultant (); BASILEA: Grant/Research Support (); Basilea Novartis Debiopharm Genentech: Advisor/Consultant (); MedImmune Bayer Janssen Contrafect Regeneron Destiny Amphliphi Integrated Bioth: Advisor/Consultant (); NIH MedImmune Allergan Theravance Novartis Merck Contrafect Karius Genentech Regeneron Janssen: Grant/Research Support ()

Disclosure(s):

Thomas L. Holland, MD: Aridis: Advisor/Consultant (); Basilea Pharmaceutica: Advisor/Consultant (); Karius: Advisor/Consultant (); Lysovant: Advisor/Consultant ()

Sara E. Cosgrove, MD: Basilea: Advisor/Consultant (); Debiopharma: Advisor/Consultant ()

Sarah B. Doernberg, MD, MAS: Basilea: Advisor/Consultant (); Genentech: Advisor/Consultant (); Gilead: Grant/Research Support (); Johnson and Johnson: Advisor/Consultant (); NIH: Grant/Research Support (); Regeneron: Grant/Research Support ()

Oleksander Pavlov, MD: No financial relationships to disclose

Ivan Titov, MD: No financial relationships to disclose

Boyko Atanasov, MD: No financial relationships to disclose

Maziar Assadi Gehr, MD: Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()

Marc Engelhardt, MD: Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()

Kamal Hamed, MD: Basilea Pharmaceutica: previous full time employee of Basilea Pharmaceutica International Ltd (); Lysovant: full time employee of Lysovant ()

Daniel Ionescu, MD: Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()

Mark Jones, PhD: Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()

Mikael Sauley, MSc: Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()

Jennifer Smart, PhD: Basilea Pharmaceutica: full time employee of Basilea Pharmaceutica International Ltd ()

Harald Seifert, MD: Basilea Pharmaceutica: Advisor/Consultant (); Debiopharm: Advisor/Consultant (); Eumedica: Advisor/Consultant (); Gilead: Advisor/Consultant (); MSD: Advisor/Consultant (); Shionogi: Advisor/Consultant ()

Timothy C. Jenkins, MD: Basilea: Clinical outcomes adjudication committee ()

Nicholas A. Turner, MD, MHSc: No financial relationships to disclose

Vance G. Fowler, MD, MHS, Jr: Armata Valanbio Akagera Aridis Roche: Advisor/Consultant (); BASILEA: Grant/Research Support (); Basilea Novartis Debiopharm Genentech: Advisor/Consultant (); MedImmune Bayer Janssen Contrafect Regeneron Destiny Amphliphi Integrated Bioth: Advisor/Consultant (); NIH MedImmune Allergan Theravance Novartis Merck Contrafect Karius Genentech Regeneron Janssen: Grant/Research Support ()